X4 Pharmaceuticals Inc (NASDAQ: XFOR) kicked off on Monday, down -3.19% from the previous trading day, before settling in for the closing price of $2.82. Over the past 52 weeks, XFOR has traded in a range of $2.67-$31.20.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
While this was happening, its average annual earnings per share was recorded -82.72%. With a float of $3.85 million, this company’s outstanding shares have now reached $5.79 million.
In an organization with 143 employees, it is important to assess its efficiency. In terms of profitability, gross margin is 82.42%, operating margin of -27.28%, and the pretax margin is 47.58%.
X4 Pharmaceuticals Inc (XFOR) Insider Updates
Our next focus will be how large-scale investors are participating in this stock of the Biotechnology Industry. The insider ownership of X4 Pharmaceuticals Inc is 33.49%, while institutional ownership is 29.32%. The most recent insider transaction that took place on May 16 ’25, was worth 2,561. In this transaction Chief Commercial Officer of this company bought 1,032 shares at a rate of $2.48, taking the stock ownership to the 25,337 shares. Before that another transaction happened on Nov 15 ’24, when Company’s Chief Commercial Officer bought 13,404 for $0.34, making the entire transaction worth $4,598. This insider now owns 129,173 shares in total.
X4 Pharmaceuticals Inc (XFOR) Performance Highlights and Predictions
According to the Wall Street analysts, stocks earnings will be around -82.72% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 50.77% during the next five years compared to 47.41% growth over the previous five years of trading.
X4 Pharmaceuticals Inc (NASDAQ: XFOR) Trading Performance Indicators
Take a look at X4 Pharmaceuticals Inc’s (XFOR) current performance indicators. Last quarter, stock had a quick ratio of 3.58. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 0.50.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is 2.24, a number that is poised to hit -2.48 in the next quarter and is forecasted to reach -8.86 in one year’s time.
Technical Analysis of X4 Pharmaceuticals Inc (XFOR)
Let’s dig in a bit further. During the last 5-days, its volume was 0.75 million. That was better than the volume of 0.16 million it reported in year-ago period. As of the previous 9 days, the stock’s Stochastic %D was 2.63%. Additionally, its Average True Range was 0.42.
During the past 100 days, X4 Pharmaceuticals Inc’s (XFOR) raw stochastic average was set at 0.28%, which indicates a significant decrease from 3.31% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 131.26% in the past 14 days, which was higher than the 124.72% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $4.26, while its 200-day Moving Average is $12.76. However, in the short run, X4 Pharmaceuticals Inc’s stock first resistance to watch stands at $2.93. Second resistance stands at $3.13. The third major resistance level sits at $3.26. If the price goes on to break the first support level at $2.60, it is likely to go to the next support level at $2.47. Assuming the price breaks the second support level, the third support level stands at $2.27.
X4 Pharmaceuticals Inc (NASDAQ: XFOR) Key Stats
The company with the Market Capitalisation of 15.80 million has total of 5,789K Shares Outstanding. Its annual sales at the moment are 2,560 K in contrast with the sum of -37,450 K annual income. Company’s last quarter sales were recorded 28,810 K and last quarter income was 280 K.
